Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Clinical trial NCT02968004 · COMPLETED

Trial details

NCT number: NCT02968004
Sponsor: OPKO Health, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2016-12-01
Primary completion: 2019-08-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.